Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) – the most common form of the chronic autoimmune disease lupus.
A multidisciplinary team of investigators at Vanderbilt University Medical Center has discovered that blocking an iron uptake receptor reduces disease pathology and promotes the activity of anti-inflammatory regulatory T cells in a mouse model of SLE.
Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) – the most common form of the chronic autoimmune disease lupus.
A multidisciplinary team of investigators at Vanderbilt University Medical Center has discovered that blocking an iron uptake receptor reduces disease pathology and promotes the activity of anti-inflammatory regulatory T cells in a mouse model of SLE.
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
